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Abstract.  Reichert's membrane,  an extraembryonic 
membrane present in developing rodents,  has been 
proposed as an in vivo model for the study of base- 
ment membranes.  We have used this membrane as a 
source for isolation of basement membrane proteogly- 
cans.  Reichert's membranes were extracted in a guani- 
dine/3-[(3-cholamidopropyl)dimethylammonio]-l-pro- 
panesulfonate buffer followed by cesium chloride 
density-gradient ultracentrifugation  under dissociative 
conditions.  The proteoglycans were subsequently 
purified from the two most dense fractions (>1.3 g/ml) 
by ion-exchange chromatography.  Mice were im- 
munized with the proteoglycan preparation and four 
mAbs recognizing the core protein of a high-density, 
buoyant chondroitin  sulfate proteoglycan were raised. 
Confirmation of antibody specificity was carried out 
by the preparation of affinity columns made from each 
of the mAbs.  Chondroitin  sulfate proteoglycans 
(CSPGs) were purified from both supernatant  and tis- 
sue fractions of Reichert's membranes incubated in 
short-term organ culture in the presence of radiolabel. 
The resultant afffinity-purified  proteoglycan samples 
were examined by gel filtration,  SDS-PAGE, and im- 
munoblotting.  This proteoglycan is of high molecular 
weight (Mr  =  5-6  x  109,  with a core protein of Mr 
=  ,x,1.5-1.6  x  105 and composed exclusively of chon- 
droitin sulfate chains with an average Mr  =  1.6-i.8  x 
104. In addition,  a CSPG was purified from adult rat 
kidney, whose core protein was also Mr  =  1.6  X  105. 
The proteoglycan and its core protein were also recog- 
nized by all four mAbs.  Indirect immunofluorescence 
of rat tissue sections stained with these antibodies re- 
veal a widespread distribution of this proteoglycan, 
localized specifically to Reichert's membrane and 
nearly all basement membranes of rat tissues.  In addi- 
tion to heparan  sulfate proteoglycans, it therefore ap- 
pears that at least one CSPG is a  widespread base- 
ment membrane component. 
ASF.r,  IENT membranes are highly specialized  extracel- 
lular matrices present at the interface between the pa- 
renchymal  and  mesenchymal  compartments  of tis- 
sues. A number of macromolecules have been isolated from 
basement membranes; some of the most abundant and well 
characterized  include laminin,  entactin,  fibronectin,  type IV 
collagen, and beparan sulfate proteoglycans (23, 24, 41, 42, 
44,  46,  54).  However,  although  it is clear that  basement 
membranes  provide molecular information  to tissues,  the 
physical,  biochemical,  and  biological  properties  of their 
component molecules are not well understood. 
We are currently concerned with the isolation,  character- 
ization,  and determination  of function of the proteoglycan 
component of basement membranes.  Unlike other basement 
membrane components, proteoglycans are hypervariable mol- 
ecules resulting  from variation  in glycosaminoglycan  chain 
number,  length,  sulfation,  and uronic acid epimerization  as 
well as the presence of a number of distinct core proteins (11, 
1.  Abbreviations  used in  this paper:  CHAPS,  3-(3-cholamidopropyl)di- 
methylammonio-l-propanesulfonate;  CSPG, chondroitin sulfate proteogly- 
can; DTE, dithioerythritoi; EHS, Englebreth-Holm-Swarm tumor; GAG, 
glycosaminoglycan;  NEM, N-ethylmaleimide;  TBS,  Tris-buffered  saline; 
TTBS,  TBS with 0.5%  Tween-20. 
23). These possibilities  for structural  modification  may, in 
turn, be reflected in a wide range of functions for basement 
membrane proteoglycans.  At present postulated functions in- 
clude a structural  role in maintaining tissue histoarchitecture 
(41, 46), selective filtration properties (17), sequestration  of 
growth factors  (26, 47) and extracellular  ions (1, 37), and 
regulation  of cellular differentiation (2, 8, 38). 
Basement membrane proteoglycans  have primarily been 
isolated either from in vivo sources such as glomerular base- 
ment membrane, placenta,  tumors such as the Englebreth- 
Holm-Swarm (EHS) tumor,  or in vitro sources such as the 
PYS-2 and L-2 yolk sac tumor cell lines (9,  19, 21, 24, 31, 
43, 44, 46). Reicbert's membrane, also known as the parietal 
yolk sac, has been proposed both as a source for basement 
membrane components and as a model for the study of base- 
ment membrane structure and function (25). It is a transient 
extraembryonic  membrane surrounding  the anmionic sac of 
the developing rodent fetus, first appearing on approximately 
day 8 of gestation and disappearing  •9  d later (6). The ex- 
tracellular matrix of Reichert's membrane is mainly a prod- 
uct of the adherent  parietal  endoderm cells (6, 7), and has 
similarities  to other basement membranes in that  laminin, 
type IV collagen,  fibronectin,  and heparan sulfate proteogly- 
cans all have been demonstrated in Reichert's membrane ei- 
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At the same time, it differs ultrastructuraUy from most base- 
ment membranes in that it has a structure  distinct from the 
"prototypical" lamina rara and densa-type organization (27). 
In  this  study  we  have  examined  whether  a  basement 
membrane-specific chondroitin  sulfate proteoglycan  (CSPG) 
could be demonstrated with core protein-specific antibodies, 
following earlier work which showed a widespread distribu- 
tion of the carbohydrate  chondroitin 6-sulfate in basement 
membranes (10).  We now report a panel of four mAbs that 
all recognize the core protein of a CSPG present in Reichert's 
membrane.  Immunostaining  of tissue sections with the mAbs 
show that this antigen  is located  specifically in Reichert's 
membrane and, more importantly,  it is present in the base- 
ment membrane of almost every tissue so far examined. 
Materials and Methods 
Materials 
All chemicals were from Sigma Chemical Co.  (St.  Louis,  MO)  unless 
otherwise stated. Sepharose CL-2B or -4B, DEAE-Sephacel, Mono-Q HR, 
Sephadex G-25 Superfine or G-50, and Sephacryl S-300 were all from Phar- 
macia Fine Chemicals (Piscataway, N J). EDTA was from Fisher Scientific 
(Pittsburgh,  PAL 
Isolation of  Proteoglycans from Rat Reichert's 
Membrane and Kidney 
Reichert's  Membrane.  20 timed pregnant Sprngue-Dawley  rats (Charles 
River Breeding Laboratories, Raleigh, NC) were killed on day 12 of gesta- 
tion by lethal injection of pentobarbital. The uteri were removed,  washed 
with PBS and opened and the fetus, placenta, and associated  membranes 
were removed. The Reichert's membranes were then dissected free from the 
placenta and immediately  placed in 100 mi of lysis buffer (50 mM Tris pH 
7.0, 0.1% Triton X-100, 10 mM EDTA, 100 mM epsilon-aminocaproic acid, 
5 mM benzamidine HCI, 5 mM N-ethylmaleimide  (NEM), 0.01 mM pepsta- 
tin, and 0.005 ram leupeptin.  The membranes were gently agitated in the 
buffer, and then sedimented under low-speed  centrifugation (1,000 rpm). 
The supernatant was discarded and the membranes were resuspended in ly- 
sis buffer for two further agitation/centrifugetion  cycles. After a final buffer 
wash, the membranes were resuspended in buffer (as above with 4.2 mM 
MgSO4 and lacking 10 mM EDTA). Deoxyribonuclease I was added (final 
concentration of 20 t~g/ml), and the membranes were incubated at 25°C for 
4 h. The membranes were rinsed, then suspended in 30 ml extraction buffer 
(150 mM sodium acetate pH 5.8, containing 6 M guanidine, 1 mM dithio- 
erythritol (DTE),  10 mM EDTA,  0.2 mM PMSF,  100 mM epsilon-ami- 
uocaproic acid, 4 % 3-(3-cholamidopropylammonio)-  l-propanesulfonate 
(CHAPS) (Pierce Chemical, Rockford, IL), briefly homogenized,  and then 
extracted at 4°C on an end-over-end mixer for 48 h. The extracts were cen- 
trifuged at 15,000 rpm (SA-600 rotor, Sorvall Superspeed  Centrifuge,  Sor- 
vail Instruments Div. Dupont Co., Wilmington, DE) for 15 min and the pel- 
let was  discarded.  The gnanidine concentration of the supernatant was 
adjusted to 4 M and solid cesium chloride added to give a starting density 
of 1.2 g/ml before centrifugation for 40 h at 100,000 g (Ti 50.2 rotor, Sorvall 
RC-60 Ultracentrifuge).  The contents of the tubes were divided into five 
fractions and their densities were measured.  The two most dense fractions, 
(4 and 5: buoyant density 1.30 and 1.35 g/ml, respectively)  were separately 
dialyzed into 50 mM Tris pH 8.0, containing 8 M urea, 0.2 M NaCl, 1 mM 
DTE,  10 mM EDTA, 0.2 ram PMSF, 0.1% Triton X-100 and loaded onto 
3 ×  I cm columns of DEAE-Sepbacel preequilibrated with the same buffer. 
The columns were washed sequentially  with 100 ml of buffer, 50 ml of 50 
mM sodium acetate pH 4.0, containing 8 M urea, 0.2 M NaCl, 1 mM DTE, 
10 mM EDTA, 0.2 mM PMSF, 0.1% Triton X-100, and 50 mi of the same 
buffer without Triton X-100, and then eluted in l-ml fractions with 50 mM 
sodium acetate pH 4.0, containing 8 M urea, 1.5 M NaCI,  1 mM DTE,  10 
mM EDTA,  0.2 mM PMSF.  Protein concentration of each fraction was 
checked by reading UV absorbance at 280 nm and constituents assayed by 
3-15% SDS-PAGE followed by silver staining (9). The presence of uronic 
acid in each fraction was determined by the method of Bitter and Muir (3). 
K/dney.  The extraction scheme for isolation  of proteoglycans  from rat 
kidney was similar to that described above for Reicbert's membrane, with 
the following changes. Kidneys were removed from 150 young adult rats, 
minced into 5  x  5 mm pieces,  put into cell lysis buffer (see above) chilled 
to 4°C,  homogenized in a  rotary  mill homogenizer (Yamato Scientific, 
Tokyo, Japan); the homogenate was then processed for DNase digestion as 
above. Afterwards,  the mixture was repelleted by low-speed centrifugntion 
(1,000 rpm), resuspended in 20 vol of extraction buffer, extracted  for 24 h, 
and processed through dissociative cesium chloride density gradient cen- 
trifugation.  The resultant two most dense fractions (buoyant density 1.40 
and 1.45 g/ml, respectively)  were then dialyzed  into 50 mM Tris pH 8.0, 
containing 4 M urea (Ultmtmre; Bethesda Research Laboratories, Bethesda, 
MD), 0.2 M NaCI,  1 mM DTE, 10 mM EDTA, 0.2 mM PMSF, and 0.1% 
Triton X-100 and loaded at 0.25 mi/min onto an HPLC (Gilson Co., Wor- 
thington, OH) equipped with a Mono-Q ion exchange column preequili- 
brated in the same buffer. The column was then washed with buffer at 0.5 
mi/min for I h, and then with 50 mM sodium acetate pH 4.0, containing 
4 M urea (Ultrapure, Bethesda Research Laboratories), 0.2 M NaCI,  I mM 
DTT, 10 mM EDTA, 0.2 mM PMSF, 0.1% Triton X-100 for an additional 
hour. The column was then eluted with a 20-nd, 0.2-1.5 M sodium chloride 
gradient in the acetate buffer (pH 4.0) at a flow rate of 0.25 ml/min. 1-ml 
fractions were collected, and the composition of each fraction was assayed 
by SDS-PAGE and immunoblotting with R44 antiserum after cbondroi- 
tinase ABC treatment (see below).  Those fractions found to contain CSPG 
were pooled, dialyzed  into Tris-buffered saline fIBS) with protease inhibi- 
tots (20 mM Tris [pH 7.5], 500 mM NaCI,  5 mM ben;ramidine HCI, 0.2 
mM PMSF). The glycosaminoglycan  (GAG) concentration for each sample 
was estimated  by the method of Farndale et al. (16). 
mAb Production 
BALB/c mice (Charles River Breeding Laboratories, 8-12 wk old) were im- 
munized according to the procedure of Lieberman et al. (39) with slight 
modifications.  Each mouse was injected with 200/~g of purified Reichert's 
membrane proteoglycan  emulsified  with an equal  volume  of complete 
Freund's adjuvant, distributing  the antigen subcutaneously  into the rear foot- 
pads and inguinal region. Using antigen in physiological saline, we repeated 
this procedure four times at 3--4 d intervals.  1 d after the last injection, the 
local lymph nodes draining the subcutaneous  areas of immunization were 
removed,  prepared as a cell suspension, and fused with the nonsecreting 
mouse myeloma line P3X63AB.653 according to established methods (34). 
14 d after the fusion, tissue culture supernatants  were screened by indirect 
immunofluorescence  on frozen  tissue sections of Reichert's membrane, 
skeletal  muscle,  and duodenum. Those clones whose supernatants were 
positive in the screening procedure were subcloned by limiting dilution, ex- 
panded to high density, and injected into pristane-primed BALB/c mice for 
the production of ascites  fluid.  The determination of the subclass of the 
resultant  mAbs  was  established by  Ouchterlony  plate  assay  using  Ig- 
subclass-specific antibodies (Zymed, South San Francisco,  CA). 
Purification of  lgG Fractions from Ascites Fluid 
Solid calcium chloride was added to the ascites sample to give a final con- 
centration of ,,ol mM and the sample was incubated at room temperature 
for 2 h. Any clots were removed. After overnight incubation at 4°C, further 
clots were removed and the ascfles was centrifuged at 11,500 rpm (Sorvall 
SA-60 rotor) for 60 rain at 4oc. The supernatant was diluted 1:2 with bind- 
ing buffer (pH 9.3) (Bio-Rad Laboratories, Richmond, CA) or with an alter- 
nate binding buffer (1.5 M glycine,  3 M NaCI,  pH 8.9).  Five milliliters of 
the clarified  ascites fluid was loaded at 5 ml/min onto a Protein A-MAPS 
preparative cartridge (Bio-Rad Laboratories) equilibrated with either bind- 
ing buffer. The column was eluted  at 5 ml/min with either elution buffer 
(pH 3.0) (Bio-Rad Laboratories), the pH of the eluent being adjusted  im- 
mediately  to 7.0, or 0.1 M citric acid, pH 6.0. The eluted antibodies were 
immediately  dialyzed  into coupling buffer (0.5 M NaCI,  0.1 M NaHCO3, 
pH 8.0). 
Organ Culture of  Reicherrs Membranes and Placentae 
Reichert's membranes and placentae were removed from the fetuses of four 
dams, pooled separately, and placed into 35-mm tissue-culture dishes (Bec- 
ton Dickinson & Co., Oxnard, CA) with 3 ml of DME medium (Mediatech, 
Herndon, VA) supplemented with 10% dialyzed FBS (Flow Laboratories, 
McLean,  VA) glutamine,  and penicillin/streptomycin.  Radioactive  inor- 
ganic sulfate was added to the cultures at a concentration of 250 ~Ci/mi 
(Amersham Corp., Arlington Heights, IL, SJS.1A, 1,103 Ci/mmol) and the 
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were removed from the culture medium, rinsed briefly in unlabeled medi- 
um, and processed as above for proteoglycan isolation.  The culture superna- 
rants were collected and dialyzed into TBS with protease inhibitors (20 mM 
Tris pH 7.5, containing 500 mM  NaCI,  5  mM benzamidine HCI,  and 
0.2 mM PMSF). 
Preparation of  A~inity Mam'ces and 
A~inity Chromatography 
Affinity columns (2 ml volume, 2 mg IgG/mi gel) were made by covalently 
coupling (40)  the four mAbs designated 2B5,  21)6, 5A3, and 4D5 or a 
nonimmune mouse IgG (Jackson Immunoresearch Labs, West Grove,  PA) 
to Sepharose CL-2B.  Affinity  columns were  equilibrated with immuno- 
affinity buffer (0.01 M Tris [pH 7.0] containing 0.5 M NaCI, 3 mM calcium 
acetate,  0.2 M  PMSF,  5 mM benzamidine HCI,  1% Tween 20,  and 5% 
1-methyl-2-pyrrolidinone).  Aliquots of either 35S-labeled supernatant, tis- 
sue proteoglycan  fractions from organ cultures, or purified kidney CSPGs 
(see above)  were gently mixed with the affinity  matrices for 16 h.  The 
columns were then drained, saving the flow through for future use,  and 
washed thoroughly with immunoaffinity buffer until the radiolabel content 
of the wash was  close to background. Radiolabeled proteoglycans  were 
eluted from the columns with 3 rni of 3 M sodium thiocyanate,  and the 
columns were regenerated  by washing the columns with 10 ml of immu- 
noaffinity buffer. Alternatively,  antibodies were coupled to Nalgene affinity 
chromatography units, which couple proteins to inert support matrices via 
an aldehyde linkage  (Nalgene,  Rochester,  NY), according to the methods 
described by the manufacturer and used in a manner similar to that de- 
scribed above. 
Characterization of  A~inity-purified  Proteoglycans 
The approximate mass of the 35S-labeled affinity-purified proteoglycan  was 
estimated by gel filtration on 0.5  ×  104 cm Sepharose CL-4B columns 
equilibrated in either PBS; 50 mM Tris (pH 8.0), containing 4 M guanidine, 
0.2 mM PMSF, 5 mM lqEM, 10 rnM EDTA, 0.1% Triton X-100; or 50 mM 
Tris (pH 8.0) containing 0.35 M NaCI, 0.1% SDS, 0.02% sodium azide, 0.2 
mM PMSF, 5 mM NEM, 10 mM EDTA at a flow rate of I rrd/h. The column 
was calibrated with blue dextran and dinitrophenoi-alanine  as standards.  80 
300-~d fractions were collected  and assayed for radiolabel.  Some samples 
were reduced and alkylated in the presence of SDS before chromatography 
(13). Further samples were dialyzed into distilled water and then subjected 
to alkaline elimination (13). The free GAG chains were treated overnight 
with nitrous acid (49), or dialyzed into 50 mM Tris (pH 8.0), 30 mM sodium 
acetate,  10 mM NEM, 0.2 mM PMSF, 0.02% sodium azide for overnight 
digestion with 0.1 U/ml chondroitinase AC II or ABC (ICN Biochemicals, 
Lisle,  IL).  Aliquots of the  untreated,  nitrous  acid-treated,  and  chow 
droitinase ABC-digested samples were chromatographed on a 0.5 × 31 cm 
Sephadex  G-50 column equilibrated in 20 mM Tris (pH 7.4),  containing 
1.0 M NaCI, 0.02 % sodium azide, and 350-/tl fractions were collected.  Ali- 
quots of the chondroitinnse AC If- and ABC-digested material were also 
chromatographed on a 0.5  ×  31 cm Sephadex  G-25 Superfine column in 
the same buffer and 250 ~i fractions were collected.  The fractions were ana- 
lyzed for radiolabel content. 
Bovine tracheal cartilage chondroitin sulfate  and heparin (molecular 
weight 4-6,000; Sigma Chemical Co.) GAGs were used as HPLC standards. 
The chondroitin sulfate GAG standards were prepared by chromatography 
on a Sephacryl S-300 column equilibrated in 0.2 M ammonium bicarbonate, 
collecting 1.5-nfl fractions, and detecting the GAGs in each fraction by ab- 
sorhance at 535 mn (16) after mixing 250/~1 aliquots with an equal volume 
of dimethylmethylene blue (Serva Fine Biochemicals, Garden City Park, 
NY) in formate buffer (pH 4.0) (16). Five consecutive fractions adjacent to 
(on both sides) and including the peak were pooled as separate groups and 
lyophilized.  These were then rehydrated,  and aliquots chromatographed 
over a Sephadex G-200 column (1  ×  100 cm) equilibrated in 50 mM Tris 
pH 7.4, containing 0.2 M NaC1, 0.02 % sodium azide at a flow rate of I ml/h. 
80 2-ml fractions were collected,  the presence of GAGs detected  by the 
dimethylmethylene blue colorimetric assay (see above), and the molecular 
weight estimated from the work of Wasteson (56).  Pool 1 (Kay ~  0.11, esti- 
mated Mr  =  35,000)  and pool 3  (Kay =  0.28,  estimated  Mr  =  19,000) 
GAGs were used as HPLC standards. 
GAG chain size of alkaline borohydride-treated 35S-labeled material was 
estimated by HPLC (Gilson Co.) using a Bio-Sil TSK-400 column (Bio-Rad 
Laboratories) that had been calibrated using the GAG standards  prepared 
above. The column was equilibrated in 0.02 M sodium phosphate (pH 6.8), 
containing 0.3 M sodium sulfate, 5% DMSO and run at 1 ml/min. Absor- 
hance was read at 240 nm, and 250-/~1 fractions of the eluent collected into 
tubes containing 250/~1 of dimethylmethylene blue to detect the GAG stan- 
dards (16). The radiolabei content of the fractionated 35S-labeled material 
was estimated  by liquid scintillation counting. 
Preparation of  Rat Laminin 
Rat laminin was prepared by affinity chromatography.  The rat cell line L-2 
(a gift from Dr.  Ulla Wewer, National Institutes of Health) was grown in 
roller bottles (Coming Glass, Coming Medical, Coming, NY) in DME 
with 10% FBS. The medium was harvested at regular intervals, centrifuged 
to remove  cellular debris, then protease inhibitors were added (0.2  mM 
PMSE 10 mM NEM) and the medium stored at -20°C. l0 liters of medium 
was concentrated to ,0200 rni in an ultrafiltration  cell (Amicon Corp., Dan- 
vers, MA), and centrifuged. The supernatant was discarded and the pellet 
was redissolved  in 30 ml ofa 6 M guanidine/CHAPS buffer (see above) be- 
fore exhaustive  dialysis  into immunoaffinity  buffer (see above).  This was 
repeatedly passed over a column of Sepharose 2B to which affinity-purified 
rabbit antibodies against murine laminin were coupled (40). The column 
was then washed  with immunoaffinity  buffer until the A2s0 was at back- 
ground, before elution with 3 M sodium thiocyanate.  The eluent was dia- 
lyzed into PBS, and the protein concentration adjusted to 0.5 mg/ml. The 
composition of the eluent was checked by SDS-PAGE  followed by both 
Coomassie brilliant blue and silver staining of the gel. 
Gel Electrophoresis  and lmmunoblotting 
5-~tl aliquots of ion-exchange chromatography-purified kidney proteoglycan 
fractions were diluted  in 100 #i of 50 mM Tris (pH 8.0), 30 mM sodium 
acetate,  10 mM NEM, 0.2 mM PMSF, 0.02% sodium azide and either kept 
untreated or digested overnight with chondroitinase ABC (0.03 U/100 #1). 
Affinity-purified CSPGs isolated from Reichert's membrane or kidney prep- 
arations were also treated as above then concentrated to "050 ~tl in a Speed- 
vac (Savant Instruments, Inc., Farmingdale,  NY) centrifuge.  Samples were 
reduced with DTE (13) and run on 3-15 % gradient SDS-PAGE (9) minigels. 
Gels were then fixed and processed for either silver (9) or alcian blue stain- 
ing (36), or the material was electrophoretically transferred to nitrocellulose 
or cationized nylon (Bio-Rad Laboratories) for immunoblotting. For nitro- 
cellulose,  transfer was achieved over 3 h at 50 V using the buffer system 
described by Towbin (55); transfer conditions for cationized nylon were as 
previously  described (9).  The membranes were blocked overnight with a 
solution of TBS/milk (TBS with 0.5% powdered milk) and probed with ei- 
ther a polyclonal antibody, R44, that recognizes the remaining carbohydrate 
stubs of chondroitinase ABC-digested CSPGs (13); or R48, a polyclonai an- 
tibody recognizing heparan sulfate proteoglycan (9). The membrane was in- 
cubated with a 1:100 dilution of the antibody in TBS/milk for 5 h, followed 
by three 15-rain washes with TrBS, incubation for 45 rain with a  1:1,000 
dilution of horseradish peroxidase conjugated goat anti-rabbit (Bio-Rad 
Laboratories) in TBS/milk, and washed in TTBS (3 ×  15 rain). Color de- 
velopment was  completed using 4-chloro-l-naphthol (Bio-Rad  Laborato- 
ries) as a substrate,  according to the manufacturer's instructions. For some 
blots, a biotinylated goat anti-rabbit secondary antibody (Vector Laborato- 
ries,  South San Francisco,  CA) was diluted in TBS/milk and followed by 
detection with a streptavidin/biotin-alkaline  pbosphatase complex (Vector 
Laboratories) and color-developed  using an appropriate substrate according 
to the manufacturer's instructions. 
Dot Blot and ELISA Assays 
Ion exchange-purified kidney material (2/~g/weil) or 2D6 antibody affinity- 
purified kidney CSPG (1/~g/well) were applied to cationized nylon (Bio-Rad 
Laboratories) in a dot-blotting apparatus (Bio-Rad Laboratories). The sam- 
ples were allowed to interact with the nylon for 5 h, after which the wells 
were rinsed with TBS then blocked overnight with TBS/milk.  Some of the 
wells were additionally treated with 0.1 U/mi of chondroitinase ABC for 
2 h. Afterwards,  all the wells were rinsed with three 10-rain changes of 
TTBS and the primary antibodies consisting of either the anti-CSPG mAbs 
2B5, 2D6,  5A3, 4D5,  or a chondroitin-6-sulfate-specific mAb 3B3 (5) or 
the chondroitin-4-sulfate-specific  mAb 2B6 (5) applied to the wells at con- 
centrations of 1, 5, and 10/~g protein/well.  A commercially available control 
mouse IgG was used at the same concentrations. Chondroitinase  ABC activ- 
ity was confirmed by the presence of reaction product in enzyme-treated 
wells with the anti-C-4 or -6 sulfate mAbs (5) (data not shown).  The pri- 
mary antibodies were allowed to interact with the proteoglycans for 5 h, at'- 
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1:1,000 dilution in TBS/milk of secondary antibodies consisting of either 
peroxidase-conjugated  goat anti-mouse IgG (Bio-Rad  Laboratories) (for 
mAbs 2B5, 21)6, 5A3, 4D5, and control IgG) and/or peroxidase conjugated 
goat anti-mouse IgM (Organon/Technika,  West Chester,  PA) (for mAbs 
3B3 and 2136) was applied to the wells and incubated for 1 h. Afterwards, 
the wells were washed with three 10-rain changes of TTBS. Color develop- 
ment was completed  using 4-chloro-l-naphthol as a substrate. 
Rat laminin, rat chondrosarcoma proteoglycan,  and kidney  proteogly- 
cans in 20 mM sodium bicarbonate, 20 mM sodium carbonate buffer, pH 
9.2 were adsorbed (or in the case of the CSPG, dried) overnight at 4°C onto 
a 96-well  plate (Flow  Laboratories). The wells  were washed  with PBS, 
blocked with 1% heat-treated  BSA and 1% normal goat serum, and washed 
with Tween-PBS (TPBS,  PBS with 0.05%  Tween 20). Anti-CSPG mAbs, 
polyclonal  antilaminin serum (1:200 dilution), anti-bovine nasal cartilage 
proteoglycan  antiserum (13) (1:200) or preimmuue rabbit serum (from the 
rabbit used to make the antilaminin polyclonai  antibodies) (1:200) diluted 
with TPBS, were added to the wells and incubated at 3"/°C for I h. The wells 
were washed  with TPBS, and then a  1:2,000  dilution of either alkaline 
phosphatase-conjugated  goat anti-mouse IgG or goat anti-rabbit IgG (Bio- 
Rad Laboratories), was added and the plate incubated for a further 1 h at 
3"/*C. The plate was washed with-both TPBS and PBS, color developed with 
p-nitrophenol phosphate per the manufacturer's instructions, and read on a 
microtiter plate reader (Molecular Devices,  Menlo Park, CA) at 405 nm. 
Indirect Immunofluorescence  Microscopy 
Immunostaining of frozen tissue sections with hybridoma tissue culture su- 
pernatants was performed as previously described (9). In some cases, tissue 
sections were immunostained after a prior l-h digestion with a 0.l-U/ml so- 
lution of chondroitinase ABC. Enzyme activity was confirmed by irnmuno- 
staining some tissue sections with mAb 3B3 (10), which recognizes CSPGs 
after prior digestion with chondmitinase ABC. Primary antibody localiza- 
tion was detected using FITC-conjugeted  goat anti-mouse IgG (no cross re- 
activity to rat IgG, Organon/Technika)  as a secondary antibody (1:50 dilu- 
tion). For comparison, some tissue sections were double-labeled with both 
anti-CSPG mAb 2D6 and antiserum against a small heparan sulfate pro- 
teoglycan (9) used at a 1:50 dilution. Primary antibody localization  for the 
anti-CSPG antibody was detected  as above;  the anti-heparan sulfate pro- 
teoglycan  antibody localization  was detected  by TRITC-conjugated  goat 
anti-rabbit  IgG (Organon/Technika).  In all circumstances,  the mAb was ap- 
plied first in the double staining protocol. 
For single-label  studies,  negative controls included omission of the pri- 
mary antibody, or nonimmune mouse IgG in place of the mAb and the use 
of preimmune serum from the rabbit used to raise the antiproteoglycan  se- 
rum. These controls gave background levels of fluorescence  in each case. 
Controls for double labeled studies included tissue sections stained with (a) 
single primary antibodies followed by inappropriate secondary antibodies; 
(b) one primary antibody with both secondary antibodies; (c) secondary an- 
tibodies alone.  Control b was positive only for the appropriate secondary 
antibody.  Controls a  and c were  negative. 
All  tissue  sections  were  viewed  on  a  Nikon  Optiphot  microscope 
equipped with epi-illumination optics and appropriate filters. Photomicro- 
graphs were taken on Ilford HP-5 or Kodak Ekiachrome-400 film. 
Results 
Isolation of  Proteoglycans  from Reichert's Membrane 
Tissue extracts  from '~250 Reichert's  membranes were pro- 
cessed  through  cesium chloride density-gradient  ultracen- 
trifugation under dissociative conditions. The two most dense 
fractions, having a buoyant density of 1.30 (fraction 4) and 
1.35 g/ml (fraction 5) contained 0.052 and 0.041 mg/ml uron- 
ic acid,  respectively.  Fig.  1 shows a  silver-stained  3-15% 
SDS-PAGE gel of the material  present in fractions 4 and 5. 
The composition of fraction 4  is relatively  homogeneous, 
whereas the material  found in fraction 5 shows the presence 
of many polypeptides. These fractions were separately  pro- 
cessed during the rest of the isolation protocol.  DEAE-ion 
exchange chromatography  was used  in attempts  to further 
purify and concentrate both  fractions,  but the  SDS-PAGE 
Figure 1.  Silver-stained 3-15% SDS-PAGE of 
cesium  chloride  density  gradient  fractions 4 
(lane  1)  and 5  (lane 2)  from a  rat Reichert's 
membrane preparation. The densities for each 
fraction were 1.30 and 1.35 g/ml, respectively. 
Fraction 4  consists primarily of one high-mo- 
lecular weight protein species, fraction 5 has a 
more heterogeneous protein composition. Mo- 
lecular mass markers (from top to bottom): 200 
kD,  116 kD,  94 kD,  68 kD,  43 kD. 
profiles of the eluted fractions remained virtually unchanged 
(data not shown). 
mAb Production and Screening 
Fractions 4  and 5  were separately  used as antigens to im- 
munize mice for the production of mAbs.  The resultant  fu- 
sions yielded '~650 clones, whose activities were screened 
by indirect immunofluorescence microscopy. Using specific 
immunostaining  of basement  membranes  of frozen tissue 
sections  as  a  selection  criterion,  we  were  able  to  select 
twelve  clones,  the  characterization  of  four  of  which  is 
presented below. All four clones were from a mouse injected 
with the more homogeneous fraction 4  material. 
A~nity Chromatography 
Affinity columns were made by coupling the four immune 
and control mouse IgG preparations  to Sepharose CL-2B. 
Table I shows the results of two typical affinity  purification 
procedures made with two different sets of affinity columns. 
Approximately 710,000 cpm of 35S-labeled supernatant pro- 
teoglycans  or  71,000  cpm  of 35S-labeled  tissue  extract-de- 
rived proteoglycans  (buoyant  density,  1.45  g/ml on cesium 
chloride density-gradient  centrifugation)  obtained from short- 
term organ cultures  of Reichert's  membranes were loaded 
onto the affinity columns. As Table I indicates, the monoclo- 
nal  affinity  columns  were able  to  specifically bind  35S-la- 
Table L  Affinity Purification of 35S-labeled Material 
Supernatant*  Membrane~tll 
35S-associated  cpra 
2B5  14,990  3,890 
2136  55,970  12,870 
5A3  59,160  11,250 
4D5  27,640  6,700 
IgG  45  ND§ 
Affinity purification with the mAbs covalently coupled to Sepharose CL-2B. 
The columns bind [35S]-labeled  macromolecules from both medium and cesi- 
um chloride density-gradient material obtained from Reichert's membrane in 
short-term organ culture with [35SO4]. A nonimmune mouse IgG (column 1 ) 
did not bind 3~S-labeled  material. 
* 710,000 epm loaded. 
~: 71,000 cpm loaded. 
§ Not done. 
II The proteoglycan from Reichert's membrane was taken from a cesium chlo- 
ride density gradient eentrifugation fraction of 1.45 g/ml buoyant density. 
The Journal of Cell Biology, Volume 109, 1989  3190 I 
0"  0 
0  10  20  30  40  50  60 
fraetioa 
Figure 2.  Gel chromatography on a column of Sepharose CL-4B 
of 35S-labeled, affinity purified CSPG from rat Reichert's mem- 
brane organ culture supernatant, before (open squares) and after 
(closed diamonds) reduction  and  aikylation.  The material  was 
purified with 2D6 antibody, and chromatographed in 0.1% SDS, 
0.35 M NaCI, 0.05 M Tris HCI, pH 8.0, and protease inhibitors. 
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Figure 3.  Glycosaminoglycan chains  were  prepared  from  2D6 
antibody-purified CSPG from 35S-labeled rat Reichert's membrane 
organ culture supernatants, subjected to alkaline elimination and 
chromatographed on a column of Sephadex G-25 Superfine after 
chondroitinase ABC (open squares) or chondroitinase AC II treat- 
ment (closed diamonds). Identical elution profiles after both en- 
zyme treatments indicate the absence of iduronic acid-rich regions 
in the GAG chains. 
beled proteoglycans from both the supernatant and tissue ex- 
tract-derived  material  isolated  from  organ  cultures.  The 
relative amounts of bound proteoglycan were different for 
each antibody, yet constant between different batches of af- 
finity matrix for the same antibody. These results probably 
arise from differences in the affinity of  the antibodies for pro- 
teoglycan, because the antibody loading on to each affinity 
matrix was fairly constant. Antibodies were also coupled to 
membrane affinity matrices (Nalgene), a very different solid- 
phase support. Similar results in terms of 35S-labeled mac- 
romolecular binding were seen using these supports. Further 
evidence for the specificity of  the antibodies was provided by 
the fact that all the 35S label bound to the affinity column 
was CSPG, which we have found accounts for only 44% of 
the total macromolecular radiolabel applied to the column. 
Additionally, radiolabeled GAG chains, released by alkaline 
borohydride treatment of affinity-purified proteoglycans also 
used to test the specificity of binding, were found not to be 
retained by the affinity columns. (McCarthy, K. J., and J. R. 
Couchman, unpublished results.) 
Characterization of  Affinity-purified Proteoglycan 
To determine the approximate mass of the proteoglycan rec- 
ognized by the antibodies, 35S-labeled affinity-purified pro- 
teoglycan from Reichert's membrane was  subjected to gel 
filtration on a column of Sepharose CL-4B in the presence 
of SDS. Fig. 2 shows that the proteoglycan eluted from the 
column with a K,v =  0.16, giving an Mr =  '~5-6  ×  1@ for 
the intact proteoglycan. The elufion pattern was not altered 
by prior reduction and alkylation in the presence of SDS. 
The proteoglycan also eluted with the same K,v from CL- 
4B columns equilibrated in either PBS or 4 M guanidine and 
0.5 % Triton X-100 (not shown). These results indicate that 
the proteoglycan does not exist as a multimolecular aggre- 
gate either through covalent or noncovalent associations. The 
proteoglycan was further characterized by testing its suscep- 
tibility to either nitrous acid or chondroitinase ABC,  fol- 
lowed by chromatography of the digests over a  Sephadex 
G-50 column. The results (data not shown) indicated that the 
GAG chains attached to the core protein were chondroitinase 
ABC sensitive.  In a further analysis, 35S-labeled GAG chains 
were released from the core protein by alkaline elimination 
and digested overnight with either chondroitinase AC II or 
ABC,  followed by gel filtration on a  column of Sephadex 
G-25  Superfine.  Fig.  3  shows that the glycosarninoglycan 
chains were completely susceptible to both enzymes, indi- 
cating that chondroitin sulfate is the predominant GAG, with 
undetectable levels of dermatan sulfate. 
GAG chain size was estimated by HPLC gel filtration of 
35S-labeled GAG on a TSK-400 column and compared with 
the elution profiles of  glycosaminoglycan standards of  known 
molecular size. Fig. 4 shows that the chondroitin chains de- 
rived from the Reichert's membrane proteoglycan eluted as 
a single broad peak later than the chondroitin sulfate GAG 
chains  of Mr  =  3.5  x  104, almost coincident with GAG 
chains  of Mr  =  1.9  ×  104, and  earlier than the heparin 
GAG chains (estimated Mr =  4-6 ×  103). From the elution 
profile we estimate the GAG chains to have an Mr =  '~1.6- 
1.8  ×  I(Y. 
Identification of the Basement Membrane 
CSPG Core Protein 
Although Reichert's membrane was the source of the antigen 
used to raise mAbs against basement membrane CSPG and 
short-term organ cultures provided adequate quantifies of 
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Figure 4.  HPLC gel filtration on a  TSK-400 column of alkaline 
borohydride released glycosaminoglycan chains from ass-labeled, 
affinity purified Reichert's membrane CSPG. The arrows indicate 
the elution peaks of glycosaminoglycan standards; Mr  =  35,000 
U), 19,000 (2), and 4-6,000 (3), respectively. 
McCarthy et al. Basement  Membrane Chondroitin Proteoglycan  3191 Figure 5.  (A) Silver-stained polyacrylamide gel showing the composition of fractions 12-24 of high buoyant density (>1.45  g/ml) kidney 
proteoglycans elnted from a Mono Q column. Equal volumes (5 pl) of each fraction were loaded into the wells of a 3-15% gradient SDS- 
PAGE. Fractions 15-24 show the presence of heterogeneous material typical of proteoglycan and virtually no other peptides. In contrast, 
fractions 12-14 contain a large number of polypeptides. The graph above the gel represents salt gradient used to elute the anion exchange 
column. (B) Immunoblot of a 3-15%  gradient SDS-PAGE of cartilage chondroitin sulfate proteoglycan before (lane 1) or after (lane 2) 
digestion with chondroitinase ABC. The blot was probed with antibodies which recognize the carbohydrate stubs left on the core protein 
after digestion with chondroitinase ABC. Lane 1 shows no reaction product. The cartilage proteoglycan core proteins in lane 2, were de- 
tected by the anticarbohydrate antibodies. The lack of clear resolution of a core protein is probably a result of variable amounts of keratan 
sulfate chains remaining on the core protein. This experiment served as a positive control for the experiment shown in C. (C) Immunobiot 
of a 3-15%  gradient SDS-PAGE of the material shown in figure 5A run after prior digestion with ehondroitinase ABC and probed with 
R44.  Lanes 14-22 reveal the core protein of a major CSPG present in the kidney preparation, with an Mr  =  1.6  x  l0  s. Note that no 
CSPG core protein is present in fractions 12 and 13. A second blot of the same material but probed with an anti-HSPG antiserum (see 
text) showed HSPG to be absent in this preparation (data not shown). (D) Immunoblot of a 3-15% gradient SDS-PAGE of antibody 2D6 
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beled GAG for carbohydrate analysis, we were unable to la- 
bel the core protein of the proteoglycan with radiolabeled 
amino acids using this technique. Furthermore, the yield of 
core protein from this tissue source was relatively low, due 
in part to persistent contaminating proteins that were difficult 
to remove and resulted in high losses.  Immunostaining of 
adult  rat  kidneys  with  the  anti-CSPG  mAbs  (see below) 
showed the antigen to be relatively abundant in this organ. 
In later studies it was decided to use this tissue as the source 
of purified CSPG. 
Kidney proteoglycans harvested from the most dense frac- 
tions of a cesium chloride density-gradient ultracentrifuga- 
tion preparation (>1.45 g/ml) were separated further by gra- 
dient anion exchange chromatography. As shown in Fig. 5 a, 
CSPGs  eluted from the column at  salt concentrations be- 
tween 1.0 and 1.5 M. No basement membrane HSPG was de- 
tectable by immunoblotting of these fractions with a poly- 
clonal antiserum (9). After chondroitinase ABC treatment, 
however, a major pool of CSPG core protein of M, =  1.6 × 
l0  s was detectable on immunoblots with R44 serum (Fig. 5 
c). This antiserum (13) detects all CSPGs and DSPGs after 
chondroitinase digestion, by virtue of reaction with the car- 
bohydrate stubs,  containing  unsaturated  uronic  acid.  Un- 
digested CSPG is not detectable with this antiserum, but core 
proteins can be readily resolved once chondroitinase treat- 
ment has gone to completion. As can be seen (Fig. 5 c), only 
fractions  14-24 of the salt gradient elution from the ion- 
exchange column contain CSPG, seen on the immunoblot as 
core proteins detected by R44 after chondroitinase digestion. 
No polypeptides were detected on a blot where samples were 
not chondroitinase ABC pretreated (data not shown). 
Because repeated attempts, using a variety of methods, to 
immunoblot with the four mAbs were unsuccessful, we used 
the same procedure to confirm the identity of the CSPG core 
protein, after affinity purification from pooled kidney mate- 
rial (fractions 15-24) with one of the mAbs (2D6). The core 
protein of the affinity-purified CSPG had an estimated M, of 
1.6 ×  los (Fig. 5 d). This is similar to the size of the CSPG 
core protein found in Reichert's membrane ([28], see Fig. 6), 
which could also be affinity purified with our mAbs (data not 
shown). 
We investigated the possibility that the core protein of rat 
Reichert's membrane CSPG might be antigenically related to 
that of basement membrane heparan sulfate proteoglycans. 
An immunoblot of material prepared from fraction 5 (1.45 
g/ml) of a cesium chloride density-gradient centrifugation of 
Reichert's membrane material was probed with a polyclonal 
antiserum recognizing large and small basement membrane 
heparan  sulfate  proteoglycans (9).  Fig.  6  shows  that  the 
CSPG was not recognized by this antibody, either before or 
after chondroitinase ABC digestion. 
The Anti-CSPG Antibodies Recognize the Core 
Protein of the Same Proteoglycan 
Dot blot assays were used to verify that all four monoclonal 
Figure 6. Immunoblot of  a 3-15 % 
SDS-PAGE of rat Reichert's mem- 
brane proteoglycans isolated from 
a  cesium  chloride  density  gra- 
dient fraction of >1.45 g/ml den- 
sity, untreated (lanes I and 3) or 
chondroitinase  ABC treated (lanes 
2  and 4).  The blot  was probed 
with R44 (lanes 3 and 4) and a 
polyclonal antibody  recognizing 
basement membrane HSPG (lanes 
1 and 2). The results indicate that 
although  a  CSPG  is  present  in 
this  fraction,  the  core  protein 
was not recognized by antiserum 
against HSPG. The polypeptides 
of Mr =  5.3 x  liP and 6.3 ×  liP 
are  nonspecifically  recognized 
by the antisera.  Molecular mass 
markers are the same as in Fig. 5. 
antibodies recognize the core protein of the same proteogly- 
can. Fig. 7 is a dot blot of  2D6 affinity-purified  material (Fig. 
5 D) probed with the anti-CSPG antibodies (lanes a-d) or 
a commercially available mouse IgG (lane e). All of the anti- 
CSPG antibodies recognized the affinity-purified material. 
Surprisingly, antibody 2B5 had the best performance in this 
and other dot blot assays, although it was not the antibody 
used in the affinity-purification process (see above). Fig.  8 
a  is  a  dot blot of pooled kidney material  (from fractions 
15-24, see above), before (rows 3 and 4) and after (rows 1 
and 2) digestion with chondroitinase ABC, probed with ei- 
ther the anti-CSPG antibodies (lanes a-d) or a commercially 
available mouse IgG (lane e). The anti-CSPG antibodies are 
able to detect antigen either before (rows 3 and 4) or after 
(rows 1 and 2) digestion with chondroitinase ABC.  Chon- 
droitinase ABC digestion appeared to enhance the ability of 
some of the antibodies to recognize antigen bound to the 
membrane. We have noted a similar trend on tissue sections 
digested  with  the  enzyme prior  to  immunostaining  (see 
below). 
ELISAs were performed with the anti-CSPG mAbs against 
a variety of antigens including rat kidney CSPG (Fig. 8 b), 
rat laminin,  and rat chondrosarcoma CSPG.  l_atrninin was 
tested because it is enriched in Reichert's membrane (25) and 
other basement membranes. It is both highly antigenic and 
has proteoglycan-binding properties (14, 48). The anti-CSPG 
antibodies  were able to recognize CSPG from the kidney 
preparation, but no reactivity of any of the four anti-CSPG 
antibodies was seen against rat laminin. A  strong response 
was seen with antilaminin serum (data not shown). Because 
one antibody (4D5, see below) had the capacity to stain rat 
tracheal cartilage, we also tested activity of the antibodies 
against the large rat cbondrosarcoma CSPG.  These assays 
were also  negative,  although a  positive control antiserum 
gave a  strong reaction (data not shown). 
afffinity-purified  kidney CSPG isolated from pooled fractions 15-24, before (lane 1 ) and after (lane 2) digestion with chondroitinase ABC. 
R44 antiserum was used to detect the core protein of the affinity-purified  CSPG which has an Mr =  1.6 X l0  s. The smaller peptide (,x,100 
kD) may be a degradation product of the larger core protein. A nonspecific peptide is present in both lanes. Molecular mass markers (from 
top to bottom), 200 kD, 94 kD, 68 kD, 43 kD, 25 kD. 
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afffinity-purified  proteoglycans 
probed with the anti-CSPG an- 
tibodies. 1 tzg per well of af- 
finity-purified kidney  CSPG 
was loaded into a dot-blotting 
apparatus  and  probed  with 
anti-CSPG antibody 2B5 (lane 
a), 2D6 (lane b), 5A3 (lane c), 
and 4D5 (lane d) or a control 
mouse IgG (lane e).  Rows 1, 
2, and 3 correspond to 10, 5, and 1 /~g/well of immunoglobulin. 
Row 4 was probed with secondary antibody only. Note that all the 
anti-CSPG antibodies are capable of recognizing the  same 2D6 
affinity-purified material. 
The  functions  of proteoglycans within  basement  mem- 
branes and the effect of basement membrane proteoglycans 
on cellular behavior are not well understood. Proteoglycans 
are integrated into the matrices of basement membranes, of- 
Indirect lmmunofluorescence  Microscopy 
All four of the mAbs strongly stained the basement mem- 
branes of most rat tissues examined. Fig. 9 shows examples 
of immunostaining with the mAbs on frozen tissue sections. 
In some cases, the same sections were also stained with anti- 
HSPG antiserum. The pattern of basement membrane stain- 
ing among the antibodies was essentially the same, but two 
differences were noted, mAb 5A3 weakly stained the base- 
ment membrane of skeletal muscle to the point that it was 
difficult to detect. The other three antibodies stained these 
basement membranes strongly, mAb 4D5 stained the matrix 
immediately adjacent to chondrocytes in tracheal cartilage 
(Fig. 9 H) but the other monoclonal antibodies did not. The 
results of ELISAs above, however, showed that none of the 
four mAbs recognized a  large rat cbondrosarcoma CSPG. 
One notable exception to the widespread distribution of the 
CSPG was rat kidney glomerular basement membranes (Fig. 
9 E), where a total absence of staining was apparent with all 
the mAbs in contrast to anti-HSPG serum (Fig. 9 F), which 
strongly stained these basement membranes.  The adjacent 
mesangia,  Bowman's capsule, and tubular basement mem- 
branes were, in contrast, strongly stained by all the mAbs. 
A detailed study of the tissue distribution of these proteogly- 
cans, both at the light microscopy level and at the ultrastruc- 
tural level is currently in progress. Our preliminary observa- 
tions are that all four anti-CSPG mAbs react solely with rat 
tissues. 
The specificity of  the mAbs for the CSPG core protein was 
also shown by the persistence of basement membrane-spe- 
cific immunostalning of tissue sections after prior digestion 
with chondroitinase ABC. In the case of one antibody, 5A3, 
immunostaining  was  intensified,  suggesting  that  epitopes 
recognized by 5A3  might be unmasked by chondroitinase 
ABC digestion (data not shown). 
Discussion 
Basement membranes were originally thought to serve solely 
as a support for tissues and a physical barrier separating the 
epithelial and mesenchymal compartments. In 1967, Grob- 
stein  (22)  proposed  that  extracellular  matrix  molecules 
might influence the behavior of cells with which they are as- 
sociated. From that initial hypothesis, others have shown that 
component molecules of the basement membrane can influ- 
ence cell shape and polarity (52, 58), differentiation and tis- 
sue morphogenesis (2,  15, 42), and movement (42, 53). 
Figure &  (,4) Dot blot  of ion-exchange-purified kidney CSPG 
probed with the anti-CSPG antibodies. 2/~g per well of kidney 
CSPG were probed with anti-CSPG antibody 2B5 (lane a), 2D6 
(lane b), 5A3 (lane c), and 4D5 (lane d) or a control mouse IgG 
(e). The material in rows 1 and 2 was also digested with chon- 
droitinase ABC before application of the primary antibodies. The 
material in rows 3 and 4 was left in the native state. Rows I  and 
3 and 2 and 4 correspond to 10 and 5/~g/well of immunoglobulin, 
respectively. The antibodies not only recognize material before but 
also after chondroitinase ABC digestion, demonstrating that the 
epitopes recognized by the antibodies are present on the core pro- 
tein of the molecule. In addition,  in some cases, chondroitinase 
digestion markedly improved the ability of the antibody to bind the 
antigen. (B) ELISA of  kidney proteoglycan purified by dissociative 
cesium chloride density gradient ultracentrifugation followed by 
ion-exchange chromatography (see Fig. 5 a). Kidney CSPG (2/~g/ 
well) was probed with either 5 or 1 pg/well of  anti-CSPG antibodies 
or with a nonimmune mouse IgG. The anti-CSPG antibodies are 
able to recognize the purified kidney CSPG. 2B5, I; 2D6, 8; 5A3, 
6; 4D5, ~; IgG, t2. 
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and are present in small quantities within these structures 
(21, 46), thereby making it difficult to isolate chemical quan- 
tities of these molecules. However,  some information about 
their function has become known in recent years. Basement 
membrane proteoglycans are known to interact with other 
matrix components suggesting a role in the assembly of  base- 
ment membranes (21). Basement membrane GAGs probably 
proteoglycans, have also been suggested to play a role in tis- 
sue morphogenesis (2, 8). Glomerular basement membrane 
heparan sulfate proteoglycan has been suggested as the pri- 
mary anionic barrier for glomerular filtration (17). Recently, 
it has been proposed the basement membrane proteoglycan 
of Reicbert's membrane may play a  similar role in rodent 
placentation (29). In addition, a heparan sulfate proteoglycan 
has been shown to influence gene expression in mammary 
epithelial cells (38). 
We have used both Reichert's membrane proteoglycans 
and those of adult rat kidney in the analysis of our mAbs, for 
several reasons. Although the former was the source of the 
antigen, the CSPG and its core protein proved difficult to pu- 
rify to homogeneity in sufficient quantities. Immunofluores- 
cent and immunochemical analysis indicated, however, that 
adult rat kidney was a rich source of  the CSPG, which proved 
to be amenable to purification. In addition, as a result of our 
experiments, we have shown that adult, as well as embryonic 
basement membranes contain a CSPG, with a similar core 
protein of Mr  =  '~1.5-1.6  x  10  5. All four antibodies were 
core protein specific, as shown by persistent or enhanced 
reaction on dotblots, after chondroitinase ABC digestion. 
In addition, immunofluorescence microscopy was not weak- 
ened, and was sometimes intensified, by prior chondroitin- 
ase ABC treatment of rat tissue sections. Because CSPG 
affinity-purified by the 2D6 antibody was recognized by all 
four antibodies, we infer that all the antibodies react with the 
same CSPG core protein. This is consistent with only one 
major CSPG species in Reichert's membrane (Fig. 6), and 
with similar tissue staining patterns. Finally, ELISAs showed 
reactivity of the monoclonal antibodies with kidney CSPG, 
but not with rat laminin, a highly antigenic protemglycan- 
binding basement membrane glycoprotein (14, 48). 
The 35S-labeled, affinity-purified  material from organ cul- 
tured Reichert's membrane proved resistant to nitrous acid 
degradation but sensitive to both chondroitinase ABC and 
AC II digestion, confirming the presence of a CSPG. Gel 
filtration analysis showed the intact proteoglycan to have an 
Mr =  5-6  x  10  ~, with an average glycosaminoglycan chain 
size of 1.6-1.8  x  104. Immunoblotting of the chondroitin- 
ase-digested,  affinity-purified kidney proteoglycan with a 
polyclonal antibody showed the core protein to have an Mr 
=  ,,ol.6 x  105. This is the same size core protein seen on 
immunoblots of  affinity-purified  Reichert's membrane CSPG 
(data not shown). On the basis of these characteristics, we 
believe this CSPG to be identical to that previously described 
from rat Reichert's membrane by Iozzo and Clark (28).  The 
CSPG has an unusual structure, with perhaps as many as 
13-22 chondroitin chains on each molecule, based on our 
preliminary analysis. At this point, however, we do not know 
if the molecule is additionally substituted with N- or O-linked 
oligosaccharides, which would influence the apparent core 
protein size. However, a number of heavily substituted CSPGs 
have been described from rat L-2 cells (4, 43), murine PYS- 
2 cells (13) and secretory granules (50).  However,  in these 
cases, the core proteins are much smaller than that described 
here for the Reichert's membrane CSPG. It will be interest- 
ing in the future to ascertain the possible core protein rela- 
tionships between this group of CSPGs. We have noted as 
others have previously (28, 29), that the core protein of this 
CSPG, once prepared by chondroitinase ABC treatment is 
highly insoluble with a tendency to aggregate, rendering fur- 
ther analysis very difficult. 
A  number of tissue basement membrane proteoglycans 
have now  been  isolated  from the  EHS  tumor and other 
sources (21, 24, 30, 31, 33, 35, 44, 51), but none has so far 
been a CSPG. However, both large and small proteoglycans 
of  basement membrane type have been isolated, bearing both 
beparan and dermatan sulfate or beparan and chondroitin 
sulfate chains, the former from human placenta (30) the lat- 
ter from the EHS tumor (33).  We believe for several reasons 
that the CSPG identified here as a basement membrane com- 
ponent does not share the same core protein as these previ- 
ously described. First, the core protein was not recognized 
in immunoblots by a polyclonal antiserum recognizing large 
and small beparan sulfate proteoglycans, which has cross re- 
activity with rat basement membrane proteoglycans (9). Sec- 
ond, this CSPG has a core protein of quite different size to 
those previously reported and is heavily substituted with 
chondroitin sulfate chains. In addition, a dermatan sulfate 
proteoglycan synthesized by murine PYS-2 cells (13), has a 
core protein that is  not recognized by antibodies against 
PYS-2  derived or EHS tumor-derived heparan sulfate pro- 
teoglycans (9,  12,  33).  The PYS-2  dermatan sulfate pro- 
teoglycan may be related to the CSPG discussed here since 
both core proteins are heavily substituted with glycosami- 
noglycan chains, and the PYS-2  cell line has affinities with 
parietal endoderm, these cells being mostly responsible for 
synthesis of Reichert's membrane in the rodent embryo (6, 
7). Finally, the absence of staining in the glomerular base- 
ment membrane is quite unlike that recorded with antibodies 
against large and small basement membrane heparan sulfate 
proteoglycans (9,  12, 33, 51). Our antiserum against HSPG 
does stain rat Reicbert's membrane, indicating the presence 
of one or more HSPGs in this tissue, consistent with data 
from the corresponding mouse basement membrane (45). 
The presence of CSPG as a constitutive part of basement 
membranes has, however, been long suspected, based on the 
results of earlier histochemical, biochemical, and immuno- 
histochemical studies. Investigators have shown chondroitin 
sulfate to  be  present  in  varying quantities  in  the  kidney 
mesangium (31, 32, 44),  developing submandibular gland 
(8), and blood vessels (57). Recently, using a mAb that rec- 
ognized chondroitin 6-sulfate we provided further evidence 
for a more global tissue distribution of CSPGs by showing 
staining of the basement membrane zones of nerve fibers, 
blood vessels, dermal-epidermal junction, striated muscle, 
kidney tubules, and glomerular mesangium (10, 20). We now 
show that four mAbs with anti-CSPG core protein specificity 
immunostain the basement membranes of various rat tissues. 
That all four of the mAbs preferentially stain kidney mesan- 
gium  and  not  glomerular  basement  membrane  supports 
previous data that showed that CSPG is the predominant pro- 
teoglyean within the mesangium (10, 32), but with relatively 
little in the glomerular basement membrane (31, 32, 44). 
Basement  membranes  associated  with  smooth muscle of 
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lighted in all tissue sections examined with these antibodies. 
This may also be a reflection of the fact that these areas are 
known to be rich in CSPGs (57). 
Although all four of our mAbs recognized the same anti- 
gen, there were differences in their immunostaining patterns, 
suggesting that they might recognize different epitopes on the 
same molecule. Unlike the other mAbs, 5A3 showed little or 
no staining of skeletal muscle basement membrane; however, 
it did strongly stain the muscle vasculature in the same tissue 
section. Another antibody, 4D5, immunostained the immedi- 
ate lacunar matrix surrounding chondrocytes of tracheal car- 
tilage, but none of the other mAbs shared this property. The 
nature of the antigen recognized by 4D5 in cartilage is pre- 
sently unknown, but seems not to be the large CSPG, based 
on ELISA with rat chondrosarcoma CSPG. It is possible that 
4D5  recognizes an oligosaccharide epitope shared with a 
cartilage matrix component and this is currently under inves- 
tigation. In addition, differences in tissue staining might be 
due to either differential masking of particular epitopes, or 
the absence of that particular epitope in specific matrices. 
Currently, the function of this CSPG in basement mem- 
branes is unknown, but our results show that it is a wide- 
spread component, as are a large heparan sulfate proteogly- 
can, laminin, entactin, and type IV collagen (24, 41, 42, 46, 
54). For this reason, it may be that it has a structural role 
in the basement membrane matrix. However, if our subse- 
quent studies confirm that this CSPG is absent from kidney 
glomerular basement membrane, it is clearly not essential 
for the assembly or function of this highly specialized ma- 
trix.  The work of Bernfield and co-workers (2,  8)  raised 
the possibility of variable amounts of basement membrane- 
associated CSPG in concert with the development of branch- 
ing morphology in the mouse salivary gland. This suggests an 
influence of basement membrane CSPG on cell behavior, an 
area we shall investigate in our future work. It is clear, how- 
ever, that just as in many other extracellular matrices such 
as cartilage, bone and loose connective tissue, CSPGs are a 
constituent of a large number of basement membranes in the 
mammal. 
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